These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3393)

  • 21. Epidemiology of tardive dyskinesia Part I.
    Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Pires P; Villenueve
    Dis Nerv Syst; 1976 Apr; 37(4):210-4. PubMed ID: 3394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind study.
    Slotema CW; van Harten PN; Bruggeman R; Hoek HW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):507-9. PubMed ID: 18022743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deanol in tardive dyskinesia: a preliminary report.
    Fann WE; Sullivan JL; Miller RD; McKenzie GM
    Psychopharmacologia; 1975 May; 42(2):135-7. PubMed ID: 1161974
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of phenothiazine-induced dyskinesia.
    Goldman D
    Psychopharmacology (Berl); 1976 Jun; 47(3):271-2. PubMed ID: 9653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Simpson GM; Yadalam KG; Stephanos MJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia treated with pimozide.
    Claveria LE; Teychenne PF; Calne DB; Haskayne L; Petrie A; Pallis CA; Lodge-Patch IC
    J Neurol Sci; 1975 Apr; 24(4):393-401. PubMed ID: 235013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential diagnosis of tardive dyskinesia in an older woman taking antipsychotic medication.
    Galletly C
    Ann Clin Psychiatry; 2011 Nov; 23(4):308-9. PubMed ID: 22073388
    [No Abstract]   [Full Text] [Related]  

  • 34. Deanol in the treatment of levodopa-induced dyskinesias.
    Klawans HL; Topel JL; Bergen D
    Neurology; 1975 Mar; 25(3):290-3. PubMed ID: 1167639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Deanol in tardive dyskinesia: a double-blind study (author's transl)].
    Bockenheimer S; Lucius G
    Arch Psychiatr Nervenkr (1970); 1976 Sep; 222(1):69-75. PubMed ID: 791197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia.
    Teusink JP
    Am Fam Physician; 1974 May; 9(5):101-5. PubMed ID: 4857228
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Lithium and M.R.I.H. in tardive dyskinesia.
    Ehrensing RH
    Lancet; 1974 Dec; 2(7894):1459-60. PubMed ID: 4140382
    [No Abstract]   [Full Text] [Related]  

  • 40. Lithium carbonate in the treatment of movement disorders. A critical review.
    Yassa R; Ananth J
    Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.